Stachydrine ameliorates isoproterenol‐induced cardiac hypertrophy and fibrosis by suppressing inflammation and oxidative stress through inhibiting NF‐&kgr;B and JAK/STAT signaling pathways in rats

[1]  O. Petrucci,et al.  Correction: Atorvastatin Improves Ventricular Remodeling after Myocardial Infarction by Interfering with Collagen Metabolism , 2017, PloS one.

[2]  G. Sethi,et al.  Capsazepine inhibits JAK/STAT3 signaling, tumor growth, and cell survival in prostate cancer , 2016, Oncotarget.

[3]  Yuan Li,et al.  The ROS-mediated activation of STAT-3/VEGF signaling is involved in the 27-hydroxycholesterol-induced angiogenesis in human breast cancer cells. , 2016, Toxicology letters.

[4]  Y. Tao,et al.  Strontium inhibits titanium particle-induced osteoclast activation and chronic inflammation via suppression of NF-κB pathway , 2016, Scientific Reports.

[5]  Meili Lu,et al.  Inhibition of TNF-&agr;–mediated NF-&kgr;B Activation by Ginsenoside Rg1 Contributes the Attenuation of Cardiac Hypertrophy Induced by Abdominal Aorta Coarctation , 2016, Journal of cardiovascular pharmacology.

[6]  Xiumei Gao,et al.  Danhong injection attenuates isoproterenol-induced cardiac hypertrophy by regulating p38 and NF-κb pathway. , 2016, Journal of ethnopharmacology.

[7]  B. Kuken,et al.  Effection of myocardial cell/collagen compound on ventricular electrophysiology in rats with myocardial infarction. , 2016, European review for medical and pharmacological sciences.

[8]  B. Győrffy,et al.  HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling , 2016, Oncotarget.

[9]  C. Watson,et al.  Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis , 2016, Journal of cardiovascular pharmacology and therapeutics.

[10]  Jinzhong Xu,et al.  Celecoxib prevents pressure overload‐induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress , 2015, Journal of cellular and molecular medicine.

[11]  Yan-bo Zhang,et al.  High fructose causes cardiac hypertrophy via mitochondrial signaling pathway. , 2016, American journal of translational research.

[12]  Q. Tang,et al.  Naringenin attenuates pressure overload-induced cardiac hypertrophy. , 2015, Experimental and therapeutic medicine.

[13]  Ray-Jade Chen,et al.  Moderate exercise training attenuates aging-induced cardiac inflammation, hypertrophy and fibrosis injuries of rat hearts , 2015, Oncotarget.

[14]  Heng Zhou,et al.  Taxifolin protects against cardiac hypertrophy and fibrosis during biomechanical stress of pressure overload. , 2015, Toxicology and applied pharmacology.

[15]  S. Tabassum,et al.  N-Acetyl Cysteine Inhibits Endothelin-1-Induced ROS Dependent Cardiac Hypertrophy through Superoxide Dismutase Regulation , 2015, Cell journal.

[16]  S. Topçuoğlu,et al.  The relationship between the oxidative stress and the cardiac hypertrophy in infants of diabetic mothers. , 2015, Diabetes research and clinical practice.

[17]  A. Mahmoud,et al.  Simvastatin prevents isoproterenol-induced cardiac hypertrophy through modulation of the JAK/STAT pathway , 2015, Drug design, development and therapy.

[18]  E. Pikarsky,et al.  Restoring inflammatory balance as a potential preventive strategy for inflammation induced cancer , 2015, Oncoimmunology.

[19]  Yu-Ming Kang,et al.  Inhibition of NF-κB activity in the hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by modulating cytokines and attenuating oxidative stress. , 2015, Toxicology and applied pharmacology.

[20]  Yuhong Yang,et al.  Astragaloside IV Protects against Isoproterenol-Induced Cardiac Hypertrophy by Regulating NF-κB/PGC-1α Signaling Mediated Energy Biosynthesis , 2015, PloS one.

[21]  Tong-yi Xu,et al.  Exercise preconditioning attenuates pressure overload-induced pathological cardiac hypertrophy. , 2015, International journal of clinical and experimental pathology.

[22]  W. Guo,et al.  Effects of stachydrine on norepinephrine-induced neonatal rat cardiac myocytes hypertrophy and intracellular calcium transients , 2014, BMC Complementary and Alternative Medicine.

[23]  C. Li,et al.  Intermedin protects against myocardial ischemia-reperfusion injury in hyperlipidemia rats. , 2014, Genetics and molecular research : GMR.

[24]  Weili Zhang,et al.  The histone acetyltransferase MOF overexpression blunts cardiac hypertrophy by targeting ROS in mice. , 2014, Biochemical and biophysical research communications.

[25]  T. Horng,et al.  IL-6 strikes a balance in metabolic inflammation. , 2014, Cell metabolism.

[26]  J. Haerting,et al.  Inflammation and echocardiographic parameters of ventricular hypertrophy in a cohort with preserved cardiac function , 2014, Open Heart.

[27]  A. Vickers,et al.  Isoproterenol effects evaluated in heart slices of human and rat in comparison to rat heart in vivo. , 2014, Toxicology and applied pharmacology.

[28]  Jinbao Liu,et al.  Gambogic acid suppresses pressure overload cardiac hypertrophy in rats. , 2013, American journal of cardiovascular disease.

[29]  Qunhui Yang,et al.  Effects of taurine on myocardial cGMP/cAMP ratio, antioxidant ability, and ultrastructure in cardiac hypertrophy rats induced by isoproterenol. , 2013, Advances in experimental medicine and biology.

[30]  Feng Zhang,et al.  Ligustrazine attenuates oxidative stress-induced activation of hepatic stellate cells by interrupting platelet-derived growth factor-β receptor-mediated ERK and p38 pathways. , 2012, Toxicology and applied pharmacology.

[31]  W. Guo,et al.  [Effect of Leonurus stachydrine on myocardial cell hypertrophy]. , 2012, Zhong yao cai = Zhongyaocai = Journal of Chinese medicinal materials.

[32]  M. Laakso,et al.  Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS production , 2012, EMBO molecular medicine.

[33]  G. Sun,et al.  Artemisinin, an anti-malarial agent, inhibits rat cardiac hypertrophy via inhibition of NF-κB signaling. , 2010, European journal of pharmacology.

[34]  Noel R. Rose,et al.  Proinflammatory cytokines in heart failure: double-edged swords , 2010, Heart Failure Reviews.

[35]  Harbir Singh,et al.  Potential chemoprevention of N-nitrosodiethylamine-induced hepatocarcinogenesis by polyphenolics from Acacia nilotica bark. , 2009, Chemico-biological interactions.

[36]  C. Scavone,et al.  Effects of isoproterenol treatment for 7 days on inflammatory mediators in the rat aorta. , 2008, American journal of physiology. Heart and circulatory physiology.

[37]  Juan Liu,et al.  Simvastatin prevents cardiac hypertrophy in vitro and in vivo via JAK/STAT pathway. , 2008, Life sciences.

[38]  G. Heusch,et al.  Cardioprotection by Ischemic Postconditioning Is Lost in Aged and STAT3-Deficient Mice , 2008, Circulation research.

[39]  W. Partata,et al.  Oxidative stress activates insulin-like growth factor I receptor protein expression, mediating cardiac hypertrophy induced by thyroxine , 2007, Molecular and Cellular Biochemistry.

[40]  C. Scavone,et al.  Changes in vascular reactivity following administration of isoproterenol for 1 week: a role for endothelial modulation , 2006, British journal of pharmacology.

[41]  Ji-nan Zhang,et al.  Trimetazidine improved Ca2+ handling in isoprenalinemediated myocardial injury of rats , 2006, Experimental physiology.

[42]  B. Kobilka,et al.  Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. , 2003, The Journal of clinical investigation.

[43]  Koichi Tanaka,et al.  Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte. , 2001, Journal of the American College of Cardiology.

[44]  E. Sonnenblick,et al.  Cellular basis of chronic ventricular remodeling after myocardial infarction in rats. , 1991, Circulation research.

[45]  W. Rogers,et al.  Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study. , 1991, Circulation.